Adare Pharma Solutions is a world leader in organic-phase coacervation for pharmaceutical products.
Our proprietary taste masking platforms can improve product acceptability and patient adherence
Increasingly, format flexibility is becoming a requirement to address patient issues such as swallowing. The FDA also continues to push for pediatric-friendly formulations. Taste, smell, and mouth feel are the key product features to address when developing pediatric formulations. And Incremental formulation and clinical research costs require cost-effective solutions with flexibility in manufacturing scale. These drivers are why customers continue to come back to Adare Pharma Solutions for their taste-masking challenges.

Among various taste masking strategies, physical barrier is one of the most efficient technologies, and Adare offers industrially feasible physical barrier technologies, such as Microcaps® and Optimµm®, for taste masking and dosage forms for pediatric populations.
Microencapsulation by coacervation:
As the world leader in coacervation, Adare’s Microcaps® technology is widely scene as the industry leading taste-masking solution with a wide variety of delivery formats.
|
![]() |
|
Proprietary Taste-Masking ProcessAlthough spherical particles are shown (yellow), the Microcaps® coacervation process can also be used for varying non-isometric particle shapes. Our Process Also Offers:
|

Adare’s Optimµm® technology provides innovative taste masking opportunities not seen before in oral pharmaceutical products
Optimµm® is developed and manufactured through Adare’s Precision Particle Fabrication™ technology, which produces uniform microspheres and microcapsules. Optimµm® is an elegant and robust solution with countless applications. You can learn more about how Optimµm® is manufactured using Precision Particle Fabrication™, here.

Optimµm® Multiparticulates are able to deliver:
- Uniformity
- Format Flexibility
- Dose Flexibility
- Taste Masking
- Variable Release Kinetics
- Single-step Microcapsules
The Broadest Variety of Taste-Masking Solutions in the Industry
Adare Pharma Solutions employs a variety of strategies for achieving successful taste-masking results for our customers, including:
API Taste Modifiers or Suppressants
API Solubility Modifier
|
API Barrier
API Modification Modify solubility or taste using:
|
Speak With An Expert

Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Senior Director of Drug Product Development & Site Leader at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s facilities, supporting a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.



